The Epoch Times
The Epoch Times
Focus

clinical

Companies
Companies
|
Reuters

Japan’s Shionogi Starts Phase III Clinical Trial in Vietnam for COVID-19 Vaccine

Dec 27, 2021
|
Reuters
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Japan’s Shionogi Starts Phase III Clinical Trial in Vietnam for COVID-19 Vaccine
Dec 27
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
The Epoch Times
|
Frank Fang

Fraud and Corruption in Chinese Clinical Trials Cast Doubts on Drug Safety

Cheating spans across Chinese authorities, pharmaceutical companies, third-party agencies, hospitals and people who volunteer for clinical trials.
Oct 07, 2016
|
Frank Fang
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Fraud and Corruption in Chinese Clinical Trials Cast Doubts on Drug Safety
Oct 07
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Companies
Companies
|
Reuters

Japan’s Shionogi Starts Phase III Clinical Trial in Vietnam for COVID-19 Vaccine

Dec 27, 2021
|
Reuters
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Japan’s Shionogi Starts Phase III Clinical Trial in Vietnam for COVID-19 Vaccine
Dec 27
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
The Epoch Times
|
Frank Fang

Fraud and Corruption in Chinese Clinical Trials Cast Doubts on Drug Safety

Cheating spans across Chinese authorities, pharmaceutical companies, third-party agencies, hospitals and people who volunteer for clinical trials.
Oct 07, 2016
|
Frank Fang
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Fraud and Corruption in Chinese Clinical Trials Cast Doubts on Drug Safety
Oct 07
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
home-iconepochtv-iconhealth-iconbright-iconepochfun-icon
The Epoch Times
To ensure we reach the high standards of reliability and neutrality that you expect from us, we are engaging with Ad Fontes Media to analyze our content. If you find an article you think falls short of the standard, please submit the link through this form.
Copyright © 2000 - 2025 The Epoch Times Association Inc. All Rights Reserved.